ICAM1 Is a Potential Cancer Stem Cell Marker of Esophageal Squamous Cell Carcinoma.
Esophageal squamous cell carcinoma (ESCC) accounts for about 90% of esophageal cancer diagnosed in Asian countries, with its incidence on the rise. Cancer stem cell (CSC; also known as tumor-initiating cells, TIC) is inherently resistant to cytotoxic chemotherapy and radiation and associates with po...
Main Authors: | Sheng-Ta Tsai, Po-Jen Wang, Nia-Jhen Liou, Pei-Shan Lin, Chung-Hsuan Chen, Wei-Chao Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4646358?pdf=render |
Similar Items
-
MEIS1 promotes expression of stem cell markers in esophageal squamous cell carcinoma
by: Selma Zargari, et al.
Published: (2020-08-01) -
Cardiac Dose Predicts the Response to Concurrent Chemoradiotherapy in Esophageal Squamous Cell Carcinoma
by: Yu-Chieh Ho, et al.
Published: (2023-09-01) -
Prognostic significance of systemic inflammatory response markers in patients with superficial esophageal squamous cell carcinomas
by: Chi-Jen Chen, et al.
Published: (2022-10-01) -
Clinicopathological relevance of stem cell marker growth and differentiation factor 3 in esophageal squamous cell carcinoma
by: Sara Tahbazzadeh Moghaddam, et al.
Published: (2023-04-01) -
Choroidal metastasis from esophageal squamous cell carcinoma
by: Shin-Yu Chang, et al.
Published: (2018-01-01)